Sanofi: buyers push back after last week's drop
Sanofi climbs 1.1% as buyers retake volume, and the decline still holds
Sanofi: buyers push back after last week's drop
Our view last week
Sanofi shares slipped 2.1% this week as sellers retook control of volume, 70% to 30%, after the previous rebound. The MACD, which had brushed a bullish cross, stalled, and money flow stays positive but fading. The short, under management for 13 weeks, trims its loss to just under 2%: Sanofi stock technical analysis, with earnings now behind it.
This week's summary
Sanofi's technical picture flips this week: after last week's 2.1% drop, buyers took back control of volume, 74% to 26%, and the stock climbed 1.1% on a bullish engulfing daily candle. Money flow backs the move, though the weekly price action still carries two warning flags. Sanofi stock stays under a sell signal in management for 13 weeks, a decline that holds its direction but is losing its edge.
IQS Phase
46
ordinary
Signal Strength
7
decline losing steam
Sizing
MINIMUM
Ranking
#16 / 42
EU-UK stocks
Trade P&L %
-3.02%
from signal to date, no stop loss
Rank position
ranks 16th among the 42 sell signals for European-UK stocks in our ranking, with a signal strength of 7 out of 100.
Sector context
SectorEuropean
Benchmark ETFEXV4
Sector regimein positive regime
Performanceweekly +0.89% · monthly -2.53%
SAN belongs to the european sector (reference ETF EXV4). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content